<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mpath ids='MPATH_177'>Angiogenesis</z:mpath> refers to the generation of new blood vasculature from the nearby pre-existing one and is regulated by a balance between the pro- and anti-angiogenic factors </plain></SENT>
<SENT sid="1" pm="."><plain>During <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e>, pro-angiogenic factors dominate and initialize the growth of new blood capillaries to provide nutrition, growth factors and overcome <z:mp ids='MP_0005039'>hypoxia</z:mp> inside the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> microenvironment </plain></SENT>
<SENT sid="2" pm="."><plain>In the present study, we have observed the role of Phosphatidylinositol-3-kinase (PI3-K)/Phophatase and tensin homolog deleted on chromosome ten (PTEN)/Akt (Protein kinase B) pathway and canonical Wnt/β-catenin downstream signaling in the regulation of various pro-angiogenic molecules including the vascular <z:chebi fb="32" ids="24621">endocrine</z:chebi> growth factor-A (VEGF-A), matix metalloproteinases (MMPs), inducible nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (iNOS) and chemokines for the progression of experimental <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> with 1,2-dimethylhydrazine dihydrochloride (DMH) and anti-angiogenic effects of two <z:chebi fb="2" ids="35475">non-steroidal anti-inflammatory drugs</z:chebi> (<z:chebi fb="1" ids="35475">NSAIDs</z:chebi>) viz </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="9352">Sulindac</z:chebi> and <z:chebi fb="0" ids="41423">Celecoxib</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Morphological and histopathological studies were performed to analyze the tumorigenic modifications while flow cytometry for the relative quantification of apoptotic events </plain></SENT>
<SENT sid="5" pm="."><plain>Transcriptional and translational modifications of biomolecules were analyzed via Reverse Transcriptase-and quantitative Real Time PCR, Western immoblotting and immunoflurescence, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>In vitro phosphorylation, gelatin zymography and nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO) assay were performed to observe the activation states of Akt, MMPs and iNOS enzyme, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>Dysregultion in Akt activation, and thereby, aberrant signaling of β-catenin along with the production of NO could positively regulate <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="1" ids="35475">NSAIDs</z:chebi> can overcome these carcinogenic effects by controlling various key check points including higher PTEN and <z:chebi fb="15" ids="28087">glycogen</z:chebi> synthase kinase-3β (GSK-3β) expression and repressing Akt, MMPs and iNOS activation while inducing <z:mpath ids='MPATH_3'>apoptosis</z:mpath> among the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
</text></document>